Release Date: 19/08/15 14:03 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 61.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%